Clinical Trial Update: RV568 - Viral Challenge With RSV [Phase 1]

View source ↗

Summary

Phase 1 trial of RV568 involving a viral challenge with respiratory syncytial virus has completed. The document provides status but does not include detailed re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• RV568

Snippet

Sponsor: Respivert Ltd | Conditions: Respiratory Syncytial Virus Infections | Phase 1 | Status: COMPLETED